In 2019, the South Korean biopharmaceutical industry produced 80 billion South Korean won worth of cell and gene therapy drugs. This represents a slight decrease from the previous year. Prior to this, production of drugs had been steadily increasing.
Value of cell and gene therapy drugs produced in South Korea from 2015 to 2019 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Value added of pharmaceutical companies in Italy 2016-2018
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Premium Statistic Immunoglobulin utilization growth 2015-2017, by diagnosis
- Premium Statistic Immunoglobulin consumption in select countries 2017
- Basic Statistic Top countries in global blood plasma market in 2017, by value
- Basic Statistic Global blood plasma market share 2017, by country
- Basic Statistic Per capita albumin consumption change 2012-2016, by country
- Premium Statistic Cost per ounce of rare cannabinoid compared to gold and diamonds in 2017
- Premium Statistic Production price of pharmaceuticals on domestic market in Italy 2005-2021
- Basic Statistic Global generic prescription drug revenues as share of prescribed revenue 2012-2026
About the region
10
- Premium Statistic Revenue of Celltrion 2013-2021
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Beijing Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
Selected statistics
6
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Premium Statistic Pfizer's ad spending 2008-2022
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
Other regions
10
- Premium Statistic Biopharmaceuticals market value in Latin America 2022-2027
- Basic Statistic Leading pharmaceutical companies in Norway 2021, by revenue
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Basic Statistic Employment at select top pharmaceutical companies in Denmark 2022
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2022
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Premium Statistic Biosimilar market size Japan 2018-2030
- Premium Statistic Physicians that received opioid-manufacturer payments in New York 2013-2015
- Premium Statistic Mexico: public medicine expenditure 2012-2018, by supplier
- Premium Statistic Pharmaceuticals production value in Colombia 2014-2020
Related statistics
10
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue Yuhan 2015-2022
- Premium Statistic Yuhan-Kimberly's sales revenue 2016-2019
- Premium Statistic Yuhan Chemical's sales revenue 2016-2019
- Premium Statistic Parenteral nutrition company market share in South Korea 2015
- Premium Statistic Revenue of GC Pharma 2015-2022
- Premium Statistic Revenue of Chong Kun Dang 2015-2022
Further related statistics
10
- Sanofi's total assets 2007-2022
- Merck & Co total assets 2009-2022
- Merck & Co - expenditure on research and development 2006-2022
- Pfizer's revenues in the U.S. and abroad 2009-2022
- Medicinal market growth worldwide including rebates 2009-2018
- Merck & Co cash dividends declared 2006-2022
- GSK's operating profit by division 2006-2021
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- AstraZeneca's expenditure on research and development 2006-2022
Further Content: You might find this interesting as well
Statistics
- Sanofi's total assets 2007-2022
- Merck & Co total assets 2009-2022
- Merck & Co - expenditure on research and development 2006-2022
- Pfizer's revenues in the U.S. and abroad 2009-2022
- Medicinal market growth worldwide including rebates 2009-2018
- Merck & Co cash dividends declared 2006-2022
- GSK's operating profit by division 2006-2021
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- AstraZeneca's expenditure on research and development 2006-2022
KHIDI. (October 22, 2021). Value of cell and gene therapy drugs produced in South Korea from 2015 to 2019 (in billion South Korean won) [Graph]. In Statista. Retrieved September 24, 2023, from https://www.statista.com/statistics/1297091/south-korea-cell-and-gene-therapy-drug-production-value/
KHIDI. "Value of cell and gene therapy drugs produced in South Korea from 2015 to 2019 (in billion South Korean won)." Chart. October 22, 2021. Statista. Accessed September 24, 2023. https://www.statista.com/statistics/1297091/south-korea-cell-and-gene-therapy-drug-production-value/
KHIDI. (2021). Value of cell and gene therapy drugs produced in South Korea from 2015 to 2019 (in billion South Korean won). Statista. Statista Inc.. Accessed: September 24, 2023. https://www.statista.com/statistics/1297091/south-korea-cell-and-gene-therapy-drug-production-value/
KHIDI. "Value of Cell and Gene Therapy Drugs Produced in South Korea from 2015 to 2019 (in Billion South Korean Won)." Statista, Statista Inc., 22 Oct 2021, https://www.statista.com/statistics/1297091/south-korea-cell-and-gene-therapy-drug-production-value/
KHIDI, Value of cell and gene therapy drugs produced in South Korea from 2015 to 2019 (in billion South Korean won) Statista, https://www.statista.com/statistics/1297091/south-korea-cell-and-gene-therapy-drug-production-value/ (last visited September 24, 2023)
Value of cell and gene therapy drugs produced in South Korea from 2015 to 2019 (in billion South Korean won) [Graph], KHIDI, October 22, 2021. [Online]. Available: https://www.statista.com/statistics/1297091/south-korea-cell-and-gene-therapy-drug-production-value/